Avalo Therapeutics Down Nearly 40%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk
Dow Jones2026/10/22 15:05Avalo Therapeutics Inc. (AVTX) is currently at $7.36, down $4.90 or 39.97%
--Would be lowest close since July 30, 2025, when it closed at $6.66
--On pace for largest percent decrease since June 26, 2023, when it fell 88.69%
--Currently down two consecutive days; down 40.45% over this period
--Worst two day stretch since the two days ending Sept. 18, 2023, when it fell 42.6%
--Down 51.99% month-to-date
--Down 59.47% year-to-date; on pace for worst year since 2023, when it fell 99.25%
--Down 99.96% from its all-time closing high of $20793.61 on Feb. 27, 2019
--Down 58.93% from 52 weeks ago (Oct. 23, 2025), when it closed at $17.92
--Down 67.82% from its 52-week closing high of $22.87 on May 7, 2026
--Would be a new 52-week closing low
--Traded as low as $6.85; lowest intraday level since July 31, 2025, when it hit $6.57
--Down 44.13% at today's intraday low; largest intraday percent decrease since June 26, 2023, when it fell as much as 88.69%
All data as of 11:02:46 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 22, 2026 11:05 ET (15:05 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Worst-Performing Altcoins This Week as BTC Battles to Hold $80K: Weekend Watch

Goldman Sachs dramatically lowers KOSPI target from 12,000 to 9,000 points, still insists there is 60% upside potential
Goldman Sachs strategists have lowered their 12-month target for South Korea's KOSPI Index from 12,000 points to 9,000 points, representing a 25% decrease. Earlier this year, Goldman had raised the target multiple times. The latest downgrade is due to mounting concerns in the market over artificial intelligence (AI) trading.

AI investment has not ended; wealth is simply being redistributed.
